Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.

Helgadottir H, Ny L, Ullenhag GJ, Falkenius J, Mikiver R, Olofsson Bagge R, Isaksson K.

DOI: 10.1093/jnci/djad081
Published: 2023-09-01
Container: J Natl Cancer Inst
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djad081,
  title = {Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.},
  author = {Helgadottir H and  Ny L and  Ullenhag GJ and  Falkenius J and  Mikiver R and  Olofsson Bagge R and  Isaksson K.},
  year = {2023},
  journal = {J Natl Cancer Inst},
  doi = {10.1093/jnci/djad081},
  url = {https://doi.org/10.1093/jnci/djad081}
}

RIS

TY  - JOUR
TI  - Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.
AU  - Helgadottir H
AU  -  Ny L
AU  -  Ullenhag GJ
AU  -  Falkenius J
AU  -  Mikiver R
AU  -  Olofsson Bagge R
AU  -  Isaksson K.
PY  - 2023
JO  - J Natl Cancer Inst
DO  - 10.1093/jnci/djad081
UR  - https://doi.org/10.1093/jnci/djad081
ER  -

APA

H, H., L, N., GJ, U., J, F., R, M., R, O. B., & K., I. (2023). Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djad081

Source records

europe-pmc · retrieved 2026-09-27T10:14:15.711Z